MM translocations juxtapose highly expressed immunoglobulin loci (IGH, IGK, and IGL) with oncogenes such as WHSC1 and MYC, leading to upregulation and tumor selective advantage. This evidence concerns the gene MYC and Miyoshi myopathy.